{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T15:47:14Z","timestamp":1779205634870,"version":"3.51.4"},"reference-count":48,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":6494,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2005,4]]},"DOI":"10.1038\/modpathol.3800323","type":"journal-article","created":{"date-parts":[[2004,11,5]],"date-time":"2004-11-05T06:58:50Z","timestamp":1099637930000},"page":"558-564","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Analysis of human equilibrative nucleoside transporter 1 (hENT1) protein in non-Hodgkin's lymphoma by immunohistochemistry"],"prefix":"10.1016","volume":"18","author":[{"given":"Laura","family":"Chow","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymond","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laith","family":"Dabbagh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Belch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James D","family":"Young","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol E","family":"Cass","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John R","family":"Mackey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/modpathol.3800323_bib1","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1034\/j.1600-0609.2003.00087.x","article-title":"Fludarabine plus cyclophosphamide for the treatment of advanced chronic lymphocytic leukemia","volume":"71","author":"Schiavone","year":"2003","journal-title":"Eur J Haematol"},{"key":"10.1038\/modpathol.3800323_bib2","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1046\/j.1365-2141.1998.00667.x","article-title":"Promising activity of gemcitabine in refractory high-grade non-Hodgkin's lymphoma","volume":"101","author":"Bernell","year":"1998","journal-title":"Br J Hematol"},{"key":"10.1038\/modpathol.3800323_bib3","unstructured":"Santaro A, Devizzi L, Bonfante V, et al. Phase II study with gemcitabine in pretreated patients with Hodgkin's disease (HD) and non-Hodgkin's lymphomas (NHL): results of a multicentre trial (meeting abstract). Proceedings of the Annual Meeting of the American Society of the Clinical Oncologists 1997, Vol. 16, p A71."},{"key":"10.1038\/modpathol.3800323_bib4","unstructured":"Garrett TJ, Rule SA, Matczak E, et al. Gemcitabine for relapsed or resistant lymphoma. Proceedings of the Annual Meeting of the American Society of the Clinical Oncologists 1999, Vol. 18, p A100."},{"key":"10.1038\/modpathol.3800323_bib5","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1023\/A:1008307528519","article-title":"Gemcitabine for relapsed or resistant lymphoma","volume":"11","author":"Savage","year":"2000","journal-title":"Ann Oncol"},{"key":"10.1038\/modpathol.3800323_bib6","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1097\/00001622-200111000-00015","article-title":"Gemcitabine in hematologic malignancies","volume":"13","author":"Nabhan","year":"2001","journal-title":"Curr Opin Oncol"},{"key":"10.1038\/modpathol.3800323_bib7","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1046\/j.1365-2141.2003.04226.x","article-title":"Gemcitabine, cisplatin and methylprednisolone chemotherapy (GEM-P) is an effective regimen in patients with poor prognostic primary progressive or multiply relapsed Hodgkin's and non-Hodgkin's lymphoma","volume":"120","author":"Chau","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1038\/modpathol.3800323_bib8","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1046\/j.1365-2141.2001.02795.x","article-title":"Gemcitabine as a single agent in the treatment of relapsed or refractory low-grade non-Hodgkin's lymphoma","volume":"113","author":"Dumontet","year":"2001","journal-title":"Br J Haematol"},{"issue":"Suppl 1","key":"10.1038\/modpathol.3800323_bib9","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1007\/s00280-002-0447-1","article-title":"Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue","volume":"49","author":"Hagemeister","year":"2002","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1038\/modpathol.3800323_bib10","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S1357-4310(99)01459-8","article-title":"Nucleoside transporters: molecular biology and implications for therapeutics development","volume":"5","author":"Baldwin","year":"1999","journal-title":"Mol Med Today"},{"key":"10.1038\/modpathol.3800323_bib11","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1093\/jnci\/91.21.1876","article-title":"Gemcitabine transport in Xenopus oocytes expressing recombinant plasma membrane mammalian nucleoside transporters","volume":"91","author":"Mackey","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"10.1038\/modpathol.3800323_bib12","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S1368-7646(98)80047-2","article-title":"The role of nucleoside transport in anticancer drug resistance","volume":"1","author":"Mackey","year":"1998","journal-title":"Drug Resist Updates"},{"key":"10.1038\/modpathol.3800323_bib13","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1042\/bj3280739","article-title":"Molecular cloning and characterization of a nitrobenzylthioinosine-insensitive (ei) equilibrative nucleoside transporter from human placenta","volume":"328","author":"Griffiths","year":"1997","journal-title":"Biochem J"},{"key":"10.1038\/modpathol.3800323_bib14","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nm0197-89","article-title":"Cloning of a human nucleoside transporter implicated in the cellular uptake of adenosine and chemotherapeutic drugs","volume":"3","author":"Griffiths","year":"1997","journal-title":"Nat Med"},{"key":"10.1038\/modpathol.3800323_bib15","doi-asserted-by":"crossref","first-page":"5288","DOI":"10.1074\/jbc.273.9.5288","article-title":"Cloning of the human equilibrative nitrobenzylmercaptopurine riboside (NBMPR)-insensitive nucleoside transporter ei by functional expression in a transport-deficient cell line","volume":"273","author":"Crawford","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1038\/modpathol.3800323_bib16","first-page":"203","article-title":"Molecular cloning, functional expression and chromosomal localiztion of a cDNA encoding a human Na+\/nucleoside cotransporter (hCNT2) selective for purine nucleosides and uridine","volume":"15","author":"Ritzel","year":"1999","journal-title":"Mol Membr Biol"},{"key":"10.1038\/modpathol.3800323_bib17","first-page":"F1058","article-title":"Na+-dependent purine nucleoside transporter from human kidney: cloning and functional characterization","volume":"273","author":"Wang","year":"1997","journal-title":"Am J Physiol"},{"key":"10.1038\/modpathol.3800323_bib18","doi-asserted-by":"crossref","first-page":"2914","DOI":"10.1074\/jbc.M007746200","article-title":"Molecular identification and characterization of novel human and mouse concentrative Na+-nucleoside cotransporter proteins (hCNT3 and mCNT3) broadly selective for purine and pyrimidine nucleosides (system cib)","volume":"276","author":"Ritzel","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1038\/modpathol.3800323_bib19","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/S0026-895X(25)09611-7","article-title":"Transport of adenosine by recombinant purine and pyrimidine-selective sodium\/nucleoside cotransporters from rat jejunum expressed in Xenopus laevis oocytes","volume":"50","author":"Yao","year":"1996","journal-title":"Mol Pharmacol"},{"key":"10.1038\/modpathol.3800323_bib20","first-page":"110","article-title":"Immunohistochemical variation of human equilibrative nucleoside transporter 1 protein in primary breast cancers","volume":"8","author":"Mackey","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.1038\/modpathol.3800323_bib21","unstructured":"Jaffe ES, Harris LN, Stein H, Vardiman JW, (eds). Pathology and Genetics of Tumours of Hematopoietic and Lymphoid Tissues: World Health Organization Classification of Tumours. IARC Press: Lyon, 2001."},{"key":"10.1038\/modpathol.3800323_bib22","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/S0028-3908(00)00207-0","article-title":"Distinct regional distribution of human equilibrative nucleoside transporter proteins 1 and 2 (hENT1 and hENT2) in the central nervous system","volume":"40","author":"Jennings","year":"2001","journal-title":"Neuropharmacology"},{"key":"10.1038\/modpathol.3800323_bib23","first-page":"3213","article-title":"Immunohistochemical variation of human equilibrative nucleoside transporter 1 protein in primary breast cancers","volume":"9","author":"Dabbagh","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1038\/modpathol.3800323_bib24","first-page":"4349","article-title":"Functional nucleoside transporters are required for gemcitabine influx and manifestation of toxicity in cancer cell lines","volume":"58","author":"Mackey","year":"1998","journal-title":"Cancer Res"},{"key":"10.1038\/modpathol.3800323_bib25","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/0277-5379(83)90029-9","article-title":"Cytosine arabinoside transport by human leukemic cells","volume":"19","author":"Wiley","year":"1983","journal-title":"Eur J Cancer Clin Oncol"},{"key":"10.1038\/modpathol.3800323_bib26","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1172\/JCI110472","article-title":"Cytosine arabinoside influx and nucleoside transport sites in acute leukemia","volume":"69","author":"Wiley","year":"1982","journal-title":"J Clin Invest"},{"key":"10.1038\/modpathol.3800323_bib27","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3109\/10428199809059245","article-title":"Es nucleoside transporter content of acute leukemia cells: role in cell sensitivity to cytarabine","volume":"32","author":"Gati","year":"1998","journal-title":"Leuk Lymphoma"},{"key":"10.1038\/modpathol.3800323_bib28","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1182\/blood.V90.1.346.346_346_353","article-title":"Sensitivity of acute leukemia cells to cytarabine is a correlate of cellular es nucleoside transporter site content measured by flow cytometry with SAENTA-fluorescein","volume":"90","author":"Gati","year":"1997","journal-title":"Blood"},{"key":"10.1038\/modpathol.3800323_bib29","doi-asserted-by":"crossref","first-page":"491","DOI":"10.3109\/10428199409049640","article-title":"Multiple myeloma: expression of nucleoside transporters on malignant plasma cells and their relationship to cellular proliferation","volume":"13","author":"Petersen","year":"1994","journal-title":"Leuk Lymphoma"},{"key":"10.1038\/modpathol.3800323_bib30","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1046\/j.1365-2141.2002.03538.x","article-title":"In vivo mechanisms of resistance to cytarabine in acute myeloid leukaemia","volume":"117","author":"Galmarini","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1038\/modpathol.3800323_bib31","first-page":"279a","article-title":"Gemcitabine membrane transport capabilities of normal human hematopoietic progenitor (CD34+) cells","volume":"94","author":"Janowska-Wieczorek","year":"1999","journal-title":"Blood"},{"key":"10.1038\/modpathol.3800323_bib32","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1182\/blood-2002-07-2236","article-title":"Fludarabine uptake mechanisms in B-cell chronic lymphocytic leukemia","volume":"101","author":"Molina-Arcas","year":"2003","journal-title":"Blood"},{"key":"10.1038\/modpathol.3800323_bib33","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1600-0609.1996.tb01932.x","article-title":"Nucleoside transporters, bcl-2 and apoptosis in CLL cells exposed to nucleoside analogues in vitro","volume":"56","author":"Petersen","year":"1996","journal-title":"Eur J Haematol"},{"key":"10.1038\/modpathol.3800323_bib34","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1042\/bj2880987","article-title":"Expression of high levels of nitrobenzylthioinosine-sensitive nucleoside transport in cultured human choriocarcinoma (BeWo) cells","volume":"288","author":"Boumah","year":"1992","journal-title":"Biochem J"},{"key":"10.1038\/modpathol.3800323_bib35","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1080\/1042819022386725","article-title":"Differential expression of human equilibrative nucleoside transporter 1 (hENT1) protein in the Reed\u2013Sternberg cells of Hodgkin\u2019s disease","volume":"43","author":"Reiman","year":"2002","journal-title":"Leuk Lymphoma"},{"key":"10.1038\/modpathol.3800323_bib36","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1182\/blood.V95.4.1443.004k55_1443_1450","article-title":"Hodgkin and Reed\u2013Sternberg cells represent an expansion of a single clone originating from a germinal center B-cell with functional immunoglobulin gene rearrangements but defective immunoglobulin transcription","volume":"95","author":"Marafioti","year":"2000","journal-title":"Blood"},{"key":"10.1038\/modpathol.3800323_bib37","doi-asserted-by":"crossref","first-page":"3804","DOI":"10.1200\/JCO.1999.17.12.3804","article-title":"Classical Hodgkin's disease and follicular lymphoma originating from the same germinal center B cell","volume":"17","author":"Marafioti","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1038\/modpathol.3800323_bib38","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/BF03402211","article-title":"Common germinal-center B-cell origin of the malignant cells in two composite lymphomas, involving classical Hodgkin's disease and either follicular lymphoma or B-CLL","volume":"7","author":"Kuppers","year":"2001","journal-title":"Mol Med"},{"key":"10.1038\/modpathol.3800323_bib39","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/bjc.1995.437","article-title":"Modulation of the equilibrative nucleoside transporter by inhibitors of DNA synthesis","volume":"72","author":"Pressacco","year":"1995","journal-title":"Br J Cancer"},{"key":"10.1038\/modpathol.3800323_bib40","first-page":"1245","article-title":"Fluctuations in nucleoside uptake and binding of the inhibitor of nucleoside transport, nitrobenzylthioinosine, during the replication cycle of HeLa cells","volume":"39","author":"Cass","year":"1979","journal-title":"Cancer Res"},{"key":"10.1038\/modpathol.3800323_bib41","first-page":"181","article-title":"ARP: Assessment of proliferative responses to granulocyte\u2013macraphage colony-stimulating factor (GM-CSF) in acute myeloid leukemia using a fluorescent ligand for the nucleoside transporter","volume":"8","author":"Wiley","year":"1994","journal-title":"Leukemia"},{"key":"10.1038\/modpathol.3800323_bib42","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1182\/blood.V74.6.2038.2038","article-title":"Nucleoside transport and proliferative rate in human thymocytes and lymphocytes","volume":"74","author":"Smith","year":"1989","journal-title":"Blood"},{"key":"10.1038\/modpathol.3800323_bib43","first-page":"1037","article-title":"Leukapheresis induced changes in cell cycle distribution and nucleoside transporters in patients with untreated acute myeloid leukemia","volume":"5","author":"Powell","year":"1991","journal-title":"Leukemia"},{"key":"10.1038\/modpathol.3800323_bib44","doi-asserted-by":"crossref","first-page":"26939","DOI":"10.1074\/jbc.273.41.26939","article-title":"Regulation of nucleoside transport by lipopolysaccharide, phorbol esters, and tumor necrosis factor-alpha in human B-lymphocytes","volume":"273","author":"Soler","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1038\/modpathol.3800323_bib45","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0014-5793(02)02622-4","article-title":"PKC regulation of the human equilibrative nucleoside transporter, hENT1","volume":"517","author":"Coe","year":"2002","journal-title":"FEBS Lett"},{"key":"10.1038\/modpathol.3800323_bib46","unstructured":"Dumontet C, Morschauser F, Bouafia F, et al. Phase II study of gemcitabine in patients with refractory or relapsing low grade lymphoproliferative malignancies. Proceedings of the Annual Meeting of the American Society of the Clinical Oncologists 1999, p A415."},{"key":"10.1038\/modpathol.3800323_bib47","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/bjc.1991.253","article-title":"Fludarabine phosphate for the treatment of low grade lymphoid malignancy","volume":"64","author":"Whelan","year":"1991","journal-title":"Br J Cancer"},{"key":"10.1038\/modpathol.3800323_bib48","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1200\/JCO.1992.10.5.790","article-title":"Phase II trial of fludarabine phosphate in lymphoma: an effective new agent in low-grade lymphoma","volume":"10","author":"Redman","year":"1992","journal-title":"J Clin Oncol"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/3800323.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/3800323","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222046634?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222046634?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/3800323.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T01:21:37Z","timestamp":1760232097000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222046634"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,4]]}},"alternative-id":["S0893395222046634"],"URL":"https:\/\/doi.org\/10.1038\/modpathol.3800323","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2005,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysis of human equilibrative nucleoside transporter 1 (hENT1) protein in non-Hodgkin's lymphoma by immunohistochemistry","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/modpathol.3800323","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2005 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}